Search results for ccnd1

163 hits were found for ccnd1

# Family MCID Name MIFTS Score
1
P BRS047 Breast Cancer 100 4.623
2
P CLR023 Colorectal Cancer 98 4.323
3
P LYM118 Lymphoma 71 3.988
4
P LNG032 Lung Cancer 99 3.896
5
MNT001 Mantle Cell Lymphoma 76 3.454
6
MYL069 Myeloma, Multiple 86 3.429
7
SQM006 Squamous Cell Carcinoma 74 3.346
8
P PNC035 Pancreatic Cancer 89 3.305
9
GST053 Gastric Cancer 84 3.132
10
ESP021 Esophageal Cancer 79 3.098
11
c LKM071 Leukemia, Chronic Lymphocytic 75 3.098
12
P HPT023 Hepatocellular Carcinoma 94 3.080
13
END057 Endometrial Cancer 76 3.080
14
HRY003 Hairy Cell Leukemia 60 3.080
15
P RTN024 Retinoblastoma 76 3.060
16
P BLD134 Bladder Cancer 78 2.887
17
P PRS040 Prostate Cancer 88 2.835
18
ADN018 Adenoma 63 2.835
19
THY028 Thyroid Cancer 72 2.815
20
PRT010 Parathyroid Carcinoma 64 2.815
21
PRT029 Parathyroid Adenoma 50 2.793
22
P ADN016 Adenocarcinoma 71 2.599
23
P BCL006 B-Cell Lymphomas 70 2.582
24
P GLM045 Glioma 61 2.582
25
P OVR042 Ovarian Cancer 82 2.522
26
P FLL037 Follicular Lymphoma 76 2.522
27
MLN008 Melanoma 72 2.522
28
LYM143 Lymphoma, Non-Hodgkin, Familial 71 2.522
29
P FML011 Familial Adenomatous Polyposis 71 2.498
30
P AST007 Astrocytoma 66 2.498
31
BRR014 Barrett Esophagus 64 2.498
32
P PNL012 Penile Cancer 58 2.498
33
P LRY044 Larynx Cancer 57 2.498
34
BRS099 Breast Ductal Carcinoma 55 2.498
35
SLV012 Salivary Gland Adenoid Cystic Carcinoma 54 2.498
36
PRL017 Prolymphocytic Leukemia 51 2.498
37
SQM013 Squamous Cell Carcinoma, Head and Neck 79 2.236
38
VNH007 Von Hippel-Lindau Syndrome 72 2.236
39
ORL015 Oral Squamous Cell Carcinoma 59 2.236
40
P EST001 Estrogen-Receptor Positive Breast Cancer 52 2.214
41
ORL011 Oral Cancer 60 2.191
42
CHR177 Chromophobe Renal Cell Carcinoma 59 2.191
43
DCT002 Ductal Carcinoma in Situ 56 2.191
44
GLB002 Glioblastoma 74 2.164
45
EWN003 Ewing Sarcoma 72 2.164
46
GLB015 Glioblastoma Multiforme 68 2.164
47
GLL018 Gallbladder Cancer 67 2.164
48
LYM129 Lymphoma, Mucosa-Associated Lymphoid Type 67 2.164
49
TNG003 Tongue Cancer 63 2.164
50
BLD034 Bile Duct Carcinoma 60 2.164
51
ATY005 Atypical Teratoid Rhabdoid Tumor 57 2.164
52
BLD131 Bladder Urothelial Carcinoma 55 2.164
53
END031 Endometrial Stromal Sarcoma 53 2.164
54
P SML016 Small Intestine Cancer 52 2.164
55
INF058 Inflammatory Myofibroblastic Tumor 49 2.164
56
PLS016 Plasma Cell Leukemia 43 2.164
57
DFF005 Diffuse Large B-Cell Lymphoma 64 1.826
58
P NSP012 Nasopharyngeal Carcinoma 71 1.799
59
ESP027 Esophagus Squamous Cell Carcinoma 45 1.799
60
ETH001 Ethmoid Sinus Adenocarcinoma 38 1.799
61
GST019 Gastrointestinal Stromal Tumor 74 1.767
62
P LYN001 Lynch Syndrome 71 1.767
63
c BSL007 Basal Cell Carcinoma 66 1.767
64
P THY109 Thyroid Cancer, Nonmedullary, 1 64 1.767
65
P LNG064 Lung Cancer Susceptibility 3 64 1.767
66
NRV006 Nervous System Cancer 61 1.767
67
OCL009 Ocular Cancer 61 1.767
68
P GST049 Gastrointestinal System Cancer 60 1.767
69
INT079 Intrahepatic Cholangiocarcinoma 60 1.767
70
c PRM005 Primary Hyperparathyroidism 59 1.767
71
PPL022 Papilloma 58 1.767
72
MRG003 Marginal Zone B-Cell Lymphoma 56 1.767
73
CLR030 Clear Cell Renal Cell Carcinoma 55 1.767
74
RTN015 Retinal Cancer 53 1.767
75
EXT010 Extramedullary Plasmacytoma 52 1.767
76
NDL021 Nodular Lymphocyte Predominant Hodgkin Lymphoma 49 1.767
77
HYP741 Hyperparathyroidism 2 with Jaw Tumors 49 1.767
78
HDR006 Hidradenocarcinoma 47 1.767
79
HMM003 Hemimegalencephaly 47 1.767
80
P PHR004 Pharynx Cancer 46 1.767
81
CLL014 Cll/sll 43 1.767
82
KRT063 Keratocystic Odontogenic Tumor 43 1.767
83
PLY040 Polymorphous Low-Grade Adenocarcinoma 42 1.767
84
INT253 Intestinal Benign Neoplasm 42 1.767
85
SYN003 Synchronous Bilateral Breast Carcinoma 41 1.767
86
MTG002 Mutagen Sensitivity 41 1.767
87
BLN002 Balanitis Xerotica Obliterans 41 1.767
88
CHN053 Chondromyxoid Fibroma 41 1.767
89
END025 Endometrial Squamous Cell Carcinoma 39 1.767
90
BWN003 Bowenoid Papulosis 37 1.767
91
ETH008 Ethmoid Sinus Cancer 36 1.767
92
LYM049 Lymphoma, Small Cleaved-Cell, Diffuse 36 1.767
93
SNS023 Sensory System Cancer 35 1.767
94
c PRM023 Pre-Malignant Neoplasm 33 1.767
95
c SKN012 Skin Carcinoma in Situ 33 1.767
96
c GST048 Gastrointestinal System Benign Neoplasm 31 1.767
97
ISC003 Ischemic Fasciitis 31 1.767
98
SPR001 Superficial Urinary Bladder Cancer 29 1.767
99
JJN007 Jejunal Adenocarcinoma 29 1.767
100
CLR137 Clear Cell Adenocarcinoma of the Ovary 27 1.767
101
SQM018 Squamous Cell Carcinoma of the Oral Tongue 27 1.767
102
NNP005 Non-Proliferative Fibrocystic Change of the Breast 27 1.767
103
P BRS060 Breast Papillomatosis 25 1.767
104
TNS013 Tonsil Squamous Cell Carcinoma 22 1.767
105
MLG070 Malignant Iris Melanoma 19 1.767
106
FML038 Female Reproductive Organ Cancer 42 1.249
107
P RPR003 Reproductive Organ Cancer 38 1.249
108
c CLL013 Cell Type Cancer 37 1.249
109
MLR006 Male Reproductive Organ Cancer 34 1.249
110
c CLL012 Cell Type Benign Neoplasm 32 1.249
111
P ESP024 Esophagitis 64 0.175
112
P LKM002 Leukemia 75 0.143
113
P CRV039 Cervicitis 49 0.113
114
P CRV035 Cervical Cancer 72 0.101
115
c SML038 Small Cell Cancer of the Lung 67 0.101
116
AGN016 Aging 65 0.087
117
PRS047 Prostatitis 59 0.087
118
P NRB001 Neuroblastoma 73 0.071
119
P LRY019 Laryngitis 57 0.071
120
P THY032 Thyroiditis 56 0.071
121
P RNL017 Renal Oncocytoma 49 0.071
122
AST005 Asthma 83 0.050
123
c LKM061 Leukemia, Acute Myeloid 81 0.050
124
LYM133 Lymphoma, Hodgkin, Classic 78 0.050
125
BDY004 Body Mass Index Quantitative Trait Locus 11 75 0.050
126
P TST021 Testicular Germ Cell Tumor 70 0.050
127
P MYL006 Myeloid Leukemia 69 0.050
128
RNL114 Renal Cell Carcinoma, Nonpapillary 68 0.050
129
SRC014 Sarcoma 68 0.050
130
P LYM026 Lymphoblastic Leukemia 66 0.050
131
c MLG068 Malignant Glioma 66 0.050
132
PTT048 Pituitary Adenoma, Prolactin-Secreting 63 0.050
133
P ANP001 Anaplastic Large Cell Lymphoma 60 0.050
134
CLR108 Colorectal Adenoma 60 0.050
135
GST040 Gastric Adenocarcinoma 60 0.050
136
P PTT006 Pituitary Adenoma 57 0.050
137
P CTN015 Cutaneous T Cell Lymphoma 56 0.050
138
HPT022 Hepatoblastoma 55 0.050
139
SPP010 Suppressor of Tumorigenicity 3 55 0.050
140
PLS009 Plasma Cell Neoplasm 51 0.050
141
BDY005 Body Mass Index Quantitative Trait Locus 9 49 0.050
142
P GNT008 Giant Cell Tumor 49 0.050
143
PTT037 Pituitary Tumors 49 0.050
144
BDY019 Body Mass Index Quantitative Trait Locus 18 48 0.050
145
ONC007 Oncocytoma 48 0.050
146
BDY017 Body Mass Index Quantitative Trait Locus 14 46 0.050
147
BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.050
148
NSP002 Nasopharyngitis 46 0.050
149
SQM022 Squamous Cell Carcinoma of the Larynx 45 0.050
150
BDY010 Body Mass Index Quantitative Trait Locus 4 45 0.050
151
ORL012 Oral Leukoplakia 45 0.050
152
BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.050
153
c FML053 Familial Colorectal Cancer 44 0.050
154
LKP003 Leukoplakia 42 0.050
155
BDY006 Body Mass Index Quantitative Trait Locus 8 42 0.050
156
BDY012 Body Mass Index Quantitative Trait Locus 7 42 0.050
157
ADN002 Adenoiditis 40 0.050
158
c LKM004 Leukemia, B-Cell, Chronic 37 0.050
159
P GRM010 Germ Cells Tumors 37 0.050
160
c LKM056 Leukemia, Chronic Lymphocytic 2 35 0.050
161
PRK066 Parkinsonism with Spasticity, X-Linked 31 0.050
162
c TST046 Testicular Germ Cell Tumor 1 26 0.050
163
c LNG109 Lung Cancer Susceptibility 1 23 0.050
Content
Loading form....